Form 4: CEO Scott Wunsch Reports Strata Critical Medical Stock Move

CEO Scott M. Wunsch acquired 57,172 shares of Strata Critical Medical upon performance criteria satisfaction and withheld 13,922 shares for taxes.

Summary

• CEO Scott M. Wunsch acquired 57,172 shares of Class A common stock on April 23, 2026, following the certification of performance-based restricted stock units (PSUs).
• On April 24, 2026, 13,922 shares were withheld by the company to satisfy tax obligations related to the vesting of these units.
• Following these transactions, the CEO holds 631,124 shares directly and 382,987 shares indirectly through a limited liability company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing documenting standard executive compensation and tax withholding events.

Positives

• The acquisition of shares by the CEO indicates the successful achievement of performance criteria established in March 2025.

Negatives

• The transaction involved a tax withholding event, which is a standard administrative process but reduces the net share gain for the executive.

Risks

• None identified in this specific ownership disclosure.

Future Outlook

The filing does not provide forward-looking guidance regarding company operations or financial performance.

Management Comments

• The transactions reflect the satisfaction of performance criteria underlying an award of performance-based restricted stock units granted on March 20, 2025.

Industry Context

StockSavvy.ai notes that executive equity vesting is a standard corporate governance practice, signaling that management is meeting pre-defined performance milestones.

Comparison to Industry Standards

• The use of performance-based restricted stock units (PSUs) aligns with standard executive compensation practices in the medical technology sector to incentivize long-term growth.
• Tax withholding upon vesting is a standard industry practice for equity-based compensation.

Related Party Transactions

• The reporting person holds 382,987 shares indirectly through a limited liability company of which he is the sole member.

Stakeholder Impact

• The transaction confirms that the CEO has met performance targets, which may be viewed positively by shareholders as an indicator of management alignment.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Strata Critical Medical, SRTA, Insider Trading, Form 4, Executive Compensation, Performance Stock Units